CSL Historical Financial Performance in US Dollars

CSL Historical Financial Performance in US Dollars

Melbourne, Australia — 23/10/2012

In February 2012, the company announced its decision to move to US dollar reporting commencing with the 2012/13 financial year. US dollars are the pharmaceutical industry standard currency for reporting purposes. The move also reflects the increasing predominance of the Company’s worldwide sales and operations in US dollars.

To assist investors during the transition the Company is today lodging with the Australian Securities Exchange sets of financial statements for the first half and full year financial 2012, restated in US dollars. A 5 year financial summary in US dollars is also provided.

The financial statements have been prepared using Accounting Policies consistent with those applied in the preparation of CSL Limited’s audited consolidated financial statements for these periods. These accounting policies can be found in Note 1 of the CSL Limited Financial Report contained in the CSL Annual Report for the relevant period and available from the company’s website www.csl.com.au. The attached financial statements are unaudited but have been subject to Agreed Upon Procedures carried out by Ernst & Young. We expect these to form the prior comparable period disclosures in the CSL Group Financial Statements for the half year ended 31 December 2012 (to be reviewed by Ernst & Young) and full year ended 30 June 2013 (to be audited by Ernst & Young).

The five year financial summary has been prepared by translating the Group’s financial statements using exchange rates and accounting policies applicable to the relevant period.

Download the release:
PDF icon CSL Historical Financial Performance in US Dollars (0.25Mb)

For further information, please contact: 
 Investor Contact:
Mark Dehring 
Head of Investor Relations 
CSL Limited 
Telephone: +613 9389 2818 
Email: mark.dehring@csl.com.au  

 Media Contact:
Sharon McHale
Snr Director, Public Affairs
CSL Limited
Mobile: +614 0997 8314
Email: sharon.mchale@csl.com.au
© 2017 CSL Limited